DuPont De Nemours (DD) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Net sales for Q3 2025 reached $3.1 billion, up 7% year-over-year, with 6% organic growth and a 1% currency benefit.
Operating EBITDA was $840 million, up 6% year-over-year, with a margin of 27.3%.
Completed the spin-off of the Electronics business (Qnity Electronics) on November 1, 2025, and announced the sale of the Aramids business, both reflected as discontinued operations.
Adjusted EPS was flat at $1.09, while GAAP EPS from continuing operations declined to $0.70 due to higher separation costs and absence of prior year gains.
Announced a $2 billion share repurchase authorization, $500 million accelerated share repurchase, and a new quarterly dividend of $0.20 per share.
Financial highlights
Organic sales growth was 6%, with a 7% volume increase and a 1% price decline; $70 million of sales were pulled forward due to customer timing.
Transaction-adjusted free cash flow was $576 million, with a conversion rate of 126%.
Operating EBITDA margin was 27.3%, down 30 bps year-over-year.
Cash provided by operating activities from continuing operations was $591 million, with capital expenditures of $146 million and $131 million in separation-related costs.
Net loss for Q3 2025 was $107 million, compared to net income of $465 million in Q3 2024, mainly due to losses from discontinued operations.
Outlook and guidance
Full-year 2025 net sales guidance is ~$6.84 billion, with operating EBITDA of ~$1.6 billion and adjusted EPS of ~$1.66.
Organic sales growth for FY25 expected at 2% year-over-year, with strength in healthcare and water offset by construction market weakness.
Q4 2025 guidance: net sales ~$1.685 billion, operating EBITDA ~$385 million, adjusted EPS ~$0.43.
Medium-term targets (2026-2028): 3%-4% organic growth, 150-200 bps margin expansion, 8%-10% EPS growth, >90% free cash flow conversion.
Management expects sufficient liquidity and financial flexibility, supported by $2.0B in cash and access to debt markets.
Latest events from DuPont De Nemours
- Q3 net sales up 4%, EBITDA up 11%, and guidance raised as business separations progress.DD
Q3 20249 Jul 2026 - Q4 sales up 7%, EBITDA up 13%, with Electronics separation set for November 1, 2025.DD
Q4 20248 Jul 2026 - Transformation targets 3–4% organic growth, 8–10% EPS CAGR, and strong cash generation by 2028.DD
Investor Day 20258 Jul 2026 - All management proposals, including a reverse stock split, were approved amid strong financial results.DD
AGM 202621 May 2026 - Q1 2026 net sales up 4%, margins and EPS surged, and 2026 guidance was raised.DD
Q1 20265 May 2026 - Board size reduced to ten after a director resignation; all other nominees remain.DD
Proxy filing15 Apr 2026 - 2025 delivered margin expansion and double-digit EPS growth; 2026 outlook strong for sales and cash flow.DD
Q4 202511 Apr 2026 - Annual meeting to vote on directors, pay, auditor, and reverse stock split amid governance focus.DD
Proxy filing10 Apr 2026 - Key proposals—director elections, pay, auditor, and reverse split—recommended for approval.DD
Proxy filing10 Apr 2026